Which therapy is categorized as 'other' for migraine prevention?

Prepare for the Pharmacology IV – Headache Therapeutics Test. Review the therapeutic approaches, tackle multiple-choice questions with explanations, and boost your test-taking confidence. Ace your exam with precision!

Botulinum toxin is categorized as 'other' because it represents an injectable, non-oral preventive with a distinct mechanism and indication compared with the common oral preventives and CGRP pathway antagonists. It’s approved specifically for chronic migraine prevention in adults (typically defined as 15 or more headache days per month) and is given in a series of injections every 12 weeks using the PREEMPT protocol. The action involves blocking neurotransmitter release at nerve terminals, including modulation of pain signaling, rather than acting through CGRP receptors or systemic daily pills. In contrast, beta-blockers are oral preventives used broadly for migraine prevention, and gepants (like atogepant) are CGRP receptor antagonists used for prevention (with rimegepant primarily used for acute treatment). Because of its unique route, mechanism, and indication, botulinum toxin sits in the 'other' category.